Systemic lupus erythematosus (SLE) Market Research Report : Forecast 2025
Download Sample Copy of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2006
Systemic lupus erythematosus (lupus) is an autoimmune disease which is characterized by inflammation of tissue in the body. Immune response is directed toward the body’s own cells, resulting in acute or chronic inflammation. Symptoms of lupus are general and hence often mistaken with symptoms of other diseases. This results in unnoticed progression of disease in the body. The disease is more common in women and usually affects individuals in the age group of 25 to 45. Although the main cause of the disease is unknown, it is linked to genetic and hormonal factors. In several instances, drug-induced lupus erythematosus is also observed commonly against drugs such as isoniazid, hydralazine, and procainamide. The diagnosis of systemic lupus erythematosus is based on distinctive clinical findings of the skin, kidneys, joints, the central nervous system, as well as on serological parameters such as antinuclear antibodies (ANA). Common symptoms include fever, fatigue, and arthralgia occurring at disease onset. Joint swelling or a butterfly rash observed particularly in women of childbearing age indicates the development of systemic lupus erythematosus (SLE).
The prevalence of lupus is higher in Europe and Australia as compared to North America. In North America, the disease is more prevalent among Hispanics, Asians, and Native Americans, according to Centers for Disease Control and Prevention (CDC). Currently no cure for lupus exists, but the disease is treated with immunosuppressants, anti-inflammatory drugs, and intravenous immunoglobulins. GlaxoSmithKline plc manufactured Benlysta (belimumab) is a B lymphocyte stimulator, which received FDA approval in 2011 for treatment of lupus. Ibuprofen and aspirin are widely prescribed anti-inflammatory drugs for suppressing symptoms of lupus. Immunosuppressants such as CellCept (Mycophenolatemofetil) by Roche, Neoral (Cyclosporine) by Novartis AG, and Imuran (Azathioprine) by GlaxoSmithKline plc are also commonly prescribed for lupus treatment.
The global systemic lupus erythematosus market is witnessing significant growth due to rising prevalence of the disease, medical advancements in the treatment of systemic lupus erythematosus or SLE, extensive research activities, and rising awareness among people about SLE treatments. The systemic lupus erythematosus market can be categorized on the basis of drug class and region. On the basis of drug class, the market can be segmented into non-steroidal anti-inflammatory drugs (NSAIDs), anti-malarial agents, corticosteroids and immunosuppressants. On the basis of geography, the market is segmented into five regions, namely North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
View Report @ http://www.transparencymarketresearch.com/systemic-lupus-erythematosus-market.html
Some of the key players operating in the systemic lupus erythematosus (SLE) market include Aurinia Pharmaceuticals Inc., Bristol-Myers Squibb Company, Cadila Healthcare, GlaxoSmithKline plc, ImmuPharma plc, Mylan N.V., F. Hoffmann-La Roche AG, and Sandoz International GmbH (Novartis AG).
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Systemic lupus erythematosus (SLE) Market Research Report : Forecast 2025 here
News-ID: 523227 • Views: 362
More Releases from Transparency Market Research
Demand in Digital Transformation Consulting Market Surges Due to Rising Demand f …
Current trends of simplifying operation models along with rising demand for consulting services to simplify various digital business processes is anticipated to fuel growth in the global digital transformation consulting market in coming years. Other major drivers for the global digital transformation consulting market include migration of conventional IT infrastructure to latest mobile computing solutions and migration of IT processes and infrastructure to digital infrastructure and cloud infrastructure. On the
Non-Woven Tapes Market to Witness an Outstanding Growth during 2021 - 2031
Non-Woven Tapes Market: An overview Non-woven tapes, being microporous in nature, have excellent permeability to air and moisture. They are easily tearable by hand and their relatively low total thickness implies that they can adjust to irregular surfaces. Having all these qualities in check, the non-woven tapes are being hugely utilized in the healthcare industry. The non-woven tapes are applicable for hygienic products, electronics and construction industry. Non-woven tapes are
Hardware Security Module (HSM) Market Sales Revenue, Grow Pricing and Industry G …
Hardware Security Module (HSM) Market: Overview According to a new market report published by Transparency Market Research the global hardware security module market is expected to reach a value of US$ 6,592.5 Mn by 2027 on account of rising security concerns across a number of industries. The market is projected to expand at a CAGR of 11.4% during the forecast period from 2020 to 2027. Growth of the hardware security
Hose Pump Market is estimated to cross US$ 1 Bn by 2031
Hose Pump Market: Introduction Transparency Market Research delivers key insights on the global hose pump market. In terms of revenue, the global hose pump market is estimated to expand at a CAGR of ~5% during the forecast period, owing to numerous factors regarding which TMR offers thorough insights and forecasts in the global hose pump market report. Obtain Report Details @ https://www.transparencymarketresearch.com/hose-pump-market.html In this market report, TMR predicts that the global hose pump
More Releases for SLE
Global Systemic Lupus Erythematosus (SLE) Medication Market Expected to Witness …
LP INFORMATION recently released a research report on the Systemic Lupus Erythematosus (SLE) Medication market analysis, which studies the Electrical Cord Reels's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Systemic Lupus Erythematosus (SLE) Medication Market 2020-2025” Research Report categorizes the global Systemic Lupus Erythematosus (SLE) Medication market by key players, product type, applications and regions,etc. The report also covers
Systemic lupus erythematosus (SLE) Market - Global Industry Analysis 2017 - 2025
Systemic lupus erythematosus (lupus) is an autoimmune disease which is characterized by inflammation of tissue in the body. Immune response is directed toward the body’s own cells, resulting in acute or chronic inflammation. Symptoms of lupus are general and hence often mistaken with symptoms of other diseases. This results in unnoticed progression of disease in the body. The disease is more common in women and usually affects individuals in the
Global Resuscitation Ventilators Market 2017 : Eternity, SIRIUSMED, Siare & SLE
The survey report by Market Research Store is an overview of the global Resuscitation Ventilators market. It covers all the recent trends including key developments in the global market in present and in future. Analyses of the global Resuscitation Ventilators market trends along with the projections of CAGRs (compound annual growth rates) are provided in the research report. Further, an evaluation of the history of the global market and the basic
Global Respiratory Devices Market-SLE Ltd, Teijin Pharma, Resmed, Weinmann
Global Respiratory Devices Market report 2017 is an in-depth research on the current situation of the Respiratory Devices industry. The Scope of the Respiratory Devices research report: The Global Respiratory Devices Market primarily includes a basic overview of the Respiratory Devices industry. It also includes Respiratory Devices definitions, classifications and applications. It segments the market by applications, types, regions, competitive players and also analyzes Respiratory Devices market size, business share and Respiratory
Systemic Lupus Erythematous SLE Drugs Market To Increase at Steady Growth Rate
Systemic Lupus Erythematous (SLE) is a chronic autoimmune disease which causes the immune system to mistakenly attack health body tissue. In SLE, body immune system can affect any part of the body, such as joints, organs, eyes, skin, etc. Often SLE can result in symptoms such as malar rash, discoid lesions, sub-acute cutaneous lesions, photosensitivity, oral ulcers, arthritis, serositis, nephropathy, neurologic involvement, thrombocytopenia, haemolytic anemia, fever, Raynaud’s phenomenon, livedo reticularis,
SuppreMol employs Protagen biomarkers in SLE study
Munich and Dortmund, Germany, August 2, 2011. SuppreMol GmbH, a privately held biopharmaceutical company developing innovative therapeutics for the treatment of autoimmune diseases and allergies, and Protagen AG, a specialist in in-vitro diagnostics and GMP-compliant protein analysis, today announced a collaboration to identify therapy-related biomarkers in patients with Systemic Lupus Erythematosus (SLE). “We will use the unique biomarker portfolio of Protagen for the rapid identification of autoantibody signatures in the